| pubmed-article:3137727 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3137727 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:3137727 | lifeskim:mentions | umls-concept:C0021745 | lld:lifeskim |
| pubmed-article:3137727 | lifeskim:mentions | umls-concept:C2003941 | lld:lifeskim |
| pubmed-article:3137727 | lifeskim:mentions | umls-concept:C2255912 | lld:lifeskim |
| pubmed-article:3137727 | lifeskim:mentions | umls-concept:C1521827 | lld:lifeskim |
| pubmed-article:3137727 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:3137727 | pubmed:dateCreated | 1988-10-6 | lld:pubmed |
| pubmed-article:3137727 | pubmed:abstractText | Preparations of human alpha- and gamma-interferon differing by the method of production and purification had different capacity of activating phagocytosis of blood polymorphonuclear leukocytes from patients with dermatoses. Native preparations of alpha- and gamma-interferon had the highest phagocytosis-activating potency. A high level of this activity was also demonstrated with human leukocyte interferon II for injections purified by highly specific methods. A concentrated preparation of human leukocyte interferon for injections with a specific activity above 1 million IU/1 mg of protein and recombinant alpha 2-interferon (reaferon) exhibited minimal phagocytosis activating effect. | lld:pubmed |
| pubmed-article:3137727 | pubmed:language | rus | lld:pubmed |
| pubmed-article:3137727 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3137727 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3137727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3137727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3137727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3137727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3137727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3137727 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3137727 | pubmed:issn | 0507-4088 | lld:pubmed |
| pubmed-article:3137727 | pubmed:author | pubmed-author:KuznetsovV... | lld:pubmed |
| pubmed-article:3137727 | pubmed:author | pubmed-author:BobkovaE VEV | lld:pubmed |
| pubmed-article:3137727 | pubmed:author | pubmed-author:KrylovO ROR | lld:pubmed |
| pubmed-article:3137727 | pubmed:author | pubmed-author:VakhrameevaN... | lld:pubmed |
| pubmed-article:3137727 | pubmed:author | pubmed-author:AvdeevaZh... | lld:pubmed |
| pubmed-article:3137727 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3137727 | pubmed:volume | 33 | lld:pubmed |
| pubmed-article:3137727 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3137727 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3137727 | pubmed:pagination | 181-4 | lld:pubmed |
| pubmed-article:3137727 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:3137727 | pubmed:meshHeading | pubmed-meshheading:3137727-... | lld:pubmed |
| pubmed-article:3137727 | pubmed:meshHeading | pubmed-meshheading:3137727-... | lld:pubmed |
| pubmed-article:3137727 | pubmed:meshHeading | pubmed-meshheading:3137727-... | lld:pubmed |
| pubmed-article:3137727 | pubmed:meshHeading | pubmed-meshheading:3137727-... | lld:pubmed |
| pubmed-article:3137727 | pubmed:meshHeading | pubmed-meshheading:3137727-... | lld:pubmed |
| pubmed-article:3137727 | pubmed:meshHeading | pubmed-meshheading:3137727-... | lld:pubmed |
| pubmed-article:3137727 | pubmed:meshHeading | pubmed-meshheading:3137727-... | lld:pubmed |
| pubmed-article:3137727 | pubmed:meshHeading | pubmed-meshheading:3137727-... | lld:pubmed |
| pubmed-article:3137727 | pubmed:meshHeading | pubmed-meshheading:3137727-... | lld:pubmed |
| pubmed-article:3137727 | pubmed:meshHeading | pubmed-meshheading:3137727-... | lld:pubmed |
| pubmed-article:3137727 | pubmed:articleTitle | [Activation of phagocytosis by preparations of human alpha and gamma interferons]. | lld:pubmed |
| pubmed-article:3137727 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3137727 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:3137727 | pubmed:publicationType | English Abstract | lld:pubmed |
